Patents by Inventor Lisa Kadyk

Lisa Kadyk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MELKS as modifiers of the Rac pathway and methods of use
    Patent number: 8067181
    Abstract: Human MELK genes are identified as modulators of the RAC pathway, and thus are therapeutic targets for disorders associated with defective RAC function. Methods for identifying modulators of RAC, comprising screening for agents that modulate the activity of MELK are provided.
    Type: Grant
    Filed: August 12, 2004
    Date of Patent: November 29, 2011
    Assignee: Exelixis, Inc.
    Inventors: Lisa Kadyk, George Ross Francis, Kim Lickteig, Timothy S. Heuer
  • Melks as Modifiers of the Rac Pathway and Methods of Use
    Publication number: 20080293044
    Abstract: Human MELK genes are identified as modulators of the RAC pathway, and thus are therapeutic targets for disorders associated with defective RAC function. Methods for identifying modulators of RAC, comprising screening for agents that modulate the activity of MELK are provided.
    Type: Application
    Filed: August 12, 2004
    Publication date: November 27, 2008
    Inventors: Lisa Kadyk, George Ross Francis, Kim Lickteig, Timothy S. Heuer
  • Mracs as modifiers of the rac pathway and methods of use
    Publication number: 20070142271
    Abstract: Human MRAC genes are identified as modulators of the RAC pathway, and thus are therapeutic targets for disorders associated with defective RAC function. Methods for identifying modulators of RAC, comprising screening for agents that modulate the activity of MRAC are provided.
    Type: Application
    Filed: November 24, 2003
    Publication date: June 21, 2007
    Applicant: Exelixis, Inc.
    Inventors: Lisa Kadyk, George Francis, Lynn Bjerke, Kim Lickteig
  • Csnks as modifiers of the rac pathway and methods of use
    Publication number: 20070141664
    Abstract: Human CSNK genes are identified as modulators of the RAC pathway, and thus are therapeutic targets for disorders associated with defective RAC function. Methods for identifying modulators of RAC, comprising screening for agents that modulate the activity of CSNK are provided.
    Type: Application
    Filed: November 24, 2003
    Publication date: June 21, 2007
    Applicant: Exelixis, Inc.
    Inventors: Lisa Kadyk, George Francis, Lynn Bjerke